Model Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Tamponade (2226)
|
Event Date 12/03/2021 |
Event Type
Injury
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Event Description
|
It was reported that a male patient born (b)(6) underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac tamponade requiring pericardiocentesis.Patient has a history of paroxysmal afib, also with typical atrial flutter.During the procedure, a pericardial effusion was noticed at the end of the case.The pericardial effusion was confirmed by a pre-effusion check with ultrasound with the ice catheter.The medical intervention provided was a pericardiocentesis and 300cc of fluid were removed and they pulled the drain.The patient was reported to be in stable condition.The physician stated abnormal anatomy and when ablating the ct line.The physician¿s opinion on the cause of this adverse event was the patient¿s unusual/abnormal anatomy, specifically in the right atrium and cavo-tricuspid isthmus, made it difficult to maintain his usual catheter stability when ablating in that area.Patient remained fully recovered with no residual effects.The patient required an overnight stay for observation post pericardiocentesis.He was dismissed the next day with no residual/remaining issues.The bayliss nrg transeptal needle (ref (b)(4)) was used.There was never evidence of a steam pop during the procedure.The pericardial effusion was not appreciated until the final/post intra-cardiac ultrasound imaging was obtained.The physician believed the acute event most likely occurred during ablation of the cti.Irrigated catheter was used in the event and the flow settings were 2ml/min for slow-flow and 15ml/min for high-flow.The correct catheter settings were selected on the generator and the pump was switching from low to high flow during ablation.No error codes were observed during the procedure.Force visualization features used: the force graph, dashboard, and vector were all used throughout the case, as was the visitag module.Visitag settings were 2mm over 3 seconds, with an fot setting of 25% for 3 seconds.Visitag size used was 3mm with no additional filter used with the visitag.Color options used prospectively: visitag color bar range was specific to fti.
|
|
Manufacturer Narrative
|
If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4) during an internal review on 27-dec-2021, noted a correction to the 3500 initial report as it was missing the physician information.Therefore, updated e.Initial reporter.
|
|
Manufacturer Narrative
|
The bwi product analysis lab received the device for evaluation on 12-jan-2022.The analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a male patient born (b)(6) 1949 underwent an atrial fibrillation (afib) ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered cardiac tamponade requiring pericardiocentesis.The device evaluation was completed on 31-jan-2022.The device was returned to biosense webster for evaluation.Bwi conducted a visual inspection and an evaluation of all its features.Visual analysis of the returned device revealed that no damage or anomalies were observed on the smart touch sf (bidirectional).Per the event, several tests were performed.The magnetic, temperature, and force features were tested, and no issues were observed.In addition, the product was deflecting and irrigating correctly.A manufacturing record evaluation was performed for the finished device batch number, and no internal actions were identified.All devices are manufactured, inspected, and released to approved specifications as part of bwi's quality process.No malfunction was observed during the product analysis.The instructions for use states that careful catheter manipulation must be performed to avoid cardiac damage, perforation, or tamponade.The root cause of the adverse event remains unknown.There may have been other circumstances or issues that occurred during the use of the device that could not be replicated during the analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|